DIABETES-ASSOCIATED OSTEOARTHRITIS: A SYNTROPY?
This review presents our own and literature data dedicated to predisposing and pathogenetic factors involved in development of a common comorbidity, diabetes-associated osteoarthritis (DAOA). So far, there is no wide-accepted clinical or scientific viewing of DAOA as a distinct clinical phenotype of...
Saved in:
Main Authors: | E. V. Kazygasheva, V. S. Shirinsky, I. V. Shirinsky |
---|---|
Format: | article |
Language: | RU |
Published: |
SPb RAACI
2016
|
Subjects: | |
Online Access: | https://doaj.org/article/7c891acefd2f44a092f26d0461ef567c |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
CLINICAL AND IMMUNOLOGICAL CHARACTERISTICS OF DIABETES-ASSOCIATED OSTEOARTHRITIS
by: I. V. Shirinsky, et al.
Published: (2015) -
CLINICAL EFFICIENCY AND SAFETY OF FENOFIBRATE, A PPARα AGONIST, IN THE PATIENTS WITH DIABETESASSOCIATED OSTEOARTHRITIS: A CROSS-OVER PILOT STUDY
by: V. S. Shirinsky, et al.
Published: (2017) -
COMORBIDITY, DNA METHYLATION AND AUTOIMMUNITY IN DIABETES-ASSOCIATED OSTEOARTHRITIS: AN EXPLORATORY STUDY
by: I. V. Shirinsky, et al.
Published: (2015) -
CLINICAL EFFICACY AND SAFETY OF ADEMETIONINE IN PATIENTS WITH DIABETES-ASSOCIATED OSTEOARTHRITIS: A CROSS-OVER PILOT STUDY
by: I. V. Shirinsky, et al.
Published: (2016) -
INFLAMMATION AND IMMUNITY: A ROLE OF PATHOGENESIS OF OSTEOARTHRITIS
by: V. S. Shirinsky, et al.
Published: (2019)